Steven A Carr

发表

Design, Implementation and Multisite Evaluation of a System Suitability Protocol for the Quantitative Assessment of Instrument Performance in Liquid Chromatography-Multiple Reaction Monitoring-MS (LC-MRM-MS)*

Christoph H Borchers, Birgit Schilling, Michael P. Cusack, 2013, Molecular & Cellular Proteomics.

Virtual Issue: Technological Innovations.

Anne-Claude Gingras, Steven A Carr, Alma L Burlingame, 2020, Molecular & cellular proteomics : MCP.

Specter: linear deconvolution for targeted analysis of data-independent acquisition mass spectrometry proteomics

Michael J MacCoss, Steven A Carr, Jacob D. Jaffe, 2018, Nature Methods.

Specter: linear deconvolution as a new paradigm for targeted analysis of data-independent acquisition mass spectrometry proteomics

Michael J MacCoss, Steven A Carr, Jacob D. Jaffe, 2017, bioRxiv.

The design, development and construction of a low cost multi-purpose computer/interface system for on-line experimentation: applications to time averaging of NMR spectra and other chemical instrumentation problems

Steven A Carr, 1976 .

Avant-garde: An automated data-driven DIA data curation tool.

Michael J MacCoss, Brendan MacLean, Nicholas Shulman, 2020, Nature Methods.

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

Steven A Carr, Nader Rifai, Michael A Gillette, 2006, Nature Biotechnology.

The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

Paul A Clemons, Aravind Subramanian, Steven A Carr, 2006, Science.

Corrigendum: Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

Christoph H Borchers, Jing Li, Birgit Schilling, 2009, Nature Biotechnology.

Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration.

Christopher R Kinsinger, Mehdi Mesri, Henry Rodriguez, 2010, Clinical chemistry.

Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry

Hasmik Keshishian, Steven A Carr, Michael A Gillette, 2017, Nature Protocols.

Refined Preparation and Use of Anti-diglycine Remnant (K-ε-GG) Antibody Enables Routine Quantification of 10,000s of Ubiquitination Sites in Single Proteomics Experiments*

D R Mani, Steven A Carr, S. Carr, 2012, Molecular & Cellular Proteomics.

Place of pattern in proteomic biomarker discovery.

Steven A Carr, Michael A Gillette, S. Carr, 2005, Journal of proteome research.

Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry*

Susan E Abbatiello, Steven A Carr, Susan E. Abbatiello, 2011, Molecular & Cellular Proteomics.

Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes*

Aravind Subramanian, Steven A Carr, Susan E. Abbatiello, 2016, Molecular & Cellular Proteomics.

Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma*

D R Mani, Steven J Skates, Steven A Carr, 2011, Molecular & Cellular Proteomics.

Integrated proteomic analysis of post-translational modifications by serial enrichment

Steven A Carr, Jacob D. Jaffe, Michael A Gillette, 2013, Nature Methods.

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Li Ding, David Fenyö, Jason M Held, 2017, Nature Communications.

Proteomic mapping in live Drosophila tissues using an engineered ascorbate peroxidase

Yanhui Hu, Steven A Carr, Norbert Perrimon, 2015, Proceedings of the National Academy of Sciences.

Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.

Christopher R Kinsinger, Mehdi Mesri, Henry Rodriguez, 2010, Clinical chemistry.

Systematic identification of human mitochondrial disease genes through integrative genomics

Sarah Calvo, Steven A Carr, Xiaohui Xie, 2006, Nature Genetics.

Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*

Xu Shi, D R Mani, Hasmik Keshishian, 2009, Molecular & Cellular Proteomics.

Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.

Birgit Schilling, Lisa J Zimmerman, Christopher R Kinsinger, 2010, Journal of proteome research.

Discovery of proteins associated with a predefined genomic locus via dCas9–APEX-mediated proximity labeling

Steven A Carr, Feng Zhang, Samuel A. Myers, 2018, Nature Methods.

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma*

Michael J MacCoss, Lee Makowski, Brendan MacLean, 2015, Molecular & Cellular Proteomics.

Interlaboratory Study Characterizing a Yeast Performance Standard for Benchmarking LC-MS Platform Performance*

Birgit Schilling, Lisa J Zimmerman, Christopher R Kinsinger, 2009, Molecular & Cellular Proteomics.

Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach

Nir Hacohen, Steven A Carr, Judy Lieberman, 2012, Nature Immunology.

Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes

Steven A Carr, Moran Yassour, Jennifer G Abelin, 2018, Nature Medicine.

Identifying the proteins to which small-molecule probes and drugs bind in cells

Steven A Carr, Adam A. Margolin, Stuart L Schreiber, 2009, Proceedings of the National Academy of Sciences.

A Human Proteome Detection and Quantitation Project*

Christoph H Borchers, Ruedi Aebersold, Steven A Carr, 2009, Molecular & Cellular Proteomics.

Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels*

Ronald J Moore, Vladislav A Petyuk, Feng Yang, 2014, Molecular & Cellular Proteomics.

Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.

Mehdi Mesri, Henry Rodriguez, Steven A Carr, 2013, Cancer discovery.

Mass Spectrometry-based Methods for Phosphorylation Site Mapping of Hyperphosphorylated Proteins Applied to Net1, a Regulator of Exit from Mitosis in Yeast*

Steven A Carr, Roland S Annan, S. Carr, 2002, Molecular & Cellular Proteomics.

Simplified and Efficient Quantification of Low-abundance Proteins at Very High Multiplex via Targeted Mass Spectrometry*

D R Mani, Hasmik Keshishian, Steven A Carr, 2014, Molecular & Cellular Proteomics.

Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.

Susan E Abbatiello, D R Mani, Hasmik Keshishian, 2010, Clinical chemistry.

Directed sample interrogation utilizing an accurate mass exclusion-based data-dependent acquisition strategy (AMEx).

Steven A Carr, Jacob D. Jaffe, Jacob D Jaffe, 2009, Journal of proteome research.

Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics.

Steven A Carr, S. Carr, R. Gerszten, 2011, Circulation research.

Proteomic and genetic approaches identify Syk as an AML target.

Tina N. Davis, Steven A Carr, William C Hahn, 2009, Cancer cell.

iTRAQ Labeling is Superior to mTRAQ for Quantitative Global Proteomics and Phosphoproteomics*

D R Mani, Steven A Carr, Jacob D. Jaffe, 2011, Molecular & Cellular Proteomics.

H2A.Z landscapes and dual modifications in pluripotent and multipotent stem cells underlie complex genome regulatory functions

Esther Rheinbay, Steven A Carr, Jacob D. Jaffe, 2012, Genome Biology.

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins

Pei Wang, Susan E Abbatiello, Henry Rodriguez, 2013, Nature Methods.

Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry.

D R Mani, Hasmik Keshishian, Steven A Carr, 2009, Clinical chemistry.

Identification of cancer cytotoxic modulators of PDE3A by predictive chemogenomics

Benito Munoz, Paul A Clemons, Aviad Tsherniak, 2015, Nature chemical biology.

Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.

Li Ding, David Fenyö, D R Mani, 2018, Cancer research.

Selective detection of glycopeptides on ion trap mass spectrometers.

Steven A Carr, S. Carr, T. Addona, 2004, Analytical chemistry.

Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.

Susan E Abbatiello, Brendan Maclean, Steven A Carr, 2010, Analytical chemistry.

Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.

Joshua LaBaer, Ann L Oberg, Christopher R Kinsinger, 2013, Journal of proteome research.

Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays.

Michael J MacCoss, Jing Chen, Brendan MacLean, 2016, Methods in molecular biology.

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.

Christian Baumgartner, Arvind Ramanathan, Oded Shaham, 2008, The Journal of clinical investigation.

TMEM258 Is a Component of the Oligosaccharyltransferase Complex Controlling ER Stress and Intestinal Inflammation.

Steven A Carr, Cisca Wijmenga, Patrick Deelen, 2016, Cell reports.

Optimizing performance of glycopeptide capture for plasma proteomics.

Frode S Berven, Steven A Carr, Rushdy Ahmad, 2010, Journal of proteome research.

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

Christoph H Borchers, Birgit Schilling, Michael P. Cusack, 2009, Nature Biotechnology.

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2

Wendy Winckler, Gad Getz, Steven A Carr, 2012, Proceedings of the National Academy of Sciences.

Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.

Chen, Li, Christopher R Kinsinger, 2017, Journal of proteome research.